In other neurodegenerative diseases, such as Parkinson’s disease and dementia with Lewy bodies, fewer differences between various phosphorylated forms of tau have been observed with both p-tau 231 and p-tau 181 showing elevations when compared to controls with no neurological disease [54, 55]. This evidence concerns the gene MAPT and nervous system disorder.